NEW YORK, Oct. 29 — Agilent Technologies and Paradigm Genetics announced a deal on Monday to develop a microarray of the whole genome of Arabidopsis thaliana

Palo Alto, Calif.-based Agilent will design, manufacture, distribute and sell the microarray. Paradigm will provide gene function expertise. The two companies plan to have the product ready for market by the end of the year. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.